Species specificity of anti-β2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation

Thrombosis and Haemostasis

Volumn 75, Issue 5, 1996, Pages 725-730

  Arvieux, J ^a,e   Darnige, L ^b   Hachulla, E ^c   Roussel, B ^a   Bensa, J C ^a   Colomb, M G ^d  

^a Centre de Transfusion Sanguine   (France)

^b CH Compiègne ^*  (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CEA GRENOBLE   (France)

^e Ctr de Transfus Sang de Grenoble   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CATTLE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029952605     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650356     Document Type: Article

References (22)

1. Triplett DA. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31.
2. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-22.
3. Harris EN, Pierangeli S, Birch D. Anticardiolipin wet workshop report: fifth international symposium on antiphospholipid antibodies. Am J Clin Pathol 1994; 101: 616-24.
4. 2-GPI in alternation of anticardiolipin binding. Int Immunol 1991; 3: 1217-21.
5. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62.
6. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994; 84: 2854-67.
7. 2-glycoprotein I as an antigen. J Immunol Meth 1991; 143: 223-9
8. Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Meth 1986; 86: 83-7.
9. 2-glycoprotein I. Br J Haematol 1992; 81: 568-73.
10. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-52.
11. Sammaritano LR, Lockshin MD, Gharavi AE. Antiphospholipid antibodies differ in aPL cofactor requirement. Lupus 1992; 1: 83-90.
12. McCarthy JM, Wagenknecht DR, McIntyre JA. Activity of antiphospholipid antibody ELISA cofactor in different animal sera. J Clin Lab Anal 1994; 8: 167-71.
13. 2-glycoprotein I to cardiolipin. Biochem J 1995; 310: 315-21.
14. 2-glycoprotein I) to anionic phospholipids. Hum Genet 1995; 95: 385-8.
15. Benjamin DC, Berzofsky JA, East IJ, Gurd FRN, Hannum C, Leach SJ, Margoliash E, Michael JG, Miller A, Prager EM, Reichlin M, Sercarz EE, Smith-Gill SJ, Todd PE, Wilson AC. The antigenic structure of proteins: a reappraisal. Ann Rev Immunol 1984; 2: 67-101.
16. 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288), and a region recognized by anticardiolipin antibodies. J Immunol 1994; 152: 653-9.
17. 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 1995; 155: 1629-36.
18. 2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome. Rheumatol Int 1995; 15: 1-8.
19. 2 glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994; 95: 310-5.
20. 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune antiphospholipid antibodies. J Immunol 1995; 155: 958-66.
21. 2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
22. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-5.